Cancer is one of the most prevalent diagnoses at nearly 40 percent. Information from the National Cancer Institute shows about 14.5 million Americans were living with cancer in 2014. This percentage is expected to rise with approximately 19 million people living with cancer in just ten years later by 2024. There are companies that are trying to reduce the numbers by helping change the prognosis like Tempus. This company was co-founded by Eric Lefkofsky to make it possible for data-enabled precision medicine.
Before Tempus there were problems with electronic health records in the healthcare industry and the firm has made it a goal to transform the way cancer care is delivered by developing a platform that analyzes the patient’s clinical and molecular data. The company developed analytics software, but it was the actual data that was a problem, so Tempus developed software that includes a natural language processing and optical character recognition capabilities. Then the physician’s notes could be transformed to data. The molecular data gathered can be processed in human genome sequencing. This can be essential in cancer patient treatment since research focuses on the molecular and cellular levels. The analysis software by Tempus can make fighting cancer and other diseases more effective. It also gives researchers hope that they can unlock the mysteries that can make advances in treating diseases like cancer.
Eric Lefkofsky entrepreneur and philanthropist along with the co-founder and CEO of Tempus technology company as well as the founder of Groupon. Mr. Lefkofsky is the co-founder of Echo Global Logistics, InterWorkings, Mediaocean, Uptake and Chicago’s venture capital firm Lightbank.
Mr. Lefkofsky attended the University of Michigan graduating with honors in 1991 and attended the University of Michigan Law School earning a Juris Doctor in 1993. In 1999 Lefkofsky and Brian Keywell started his first company. Mr. Lefkofsk joined Halo becoming the chief operating officer. By 2001 he co-founded InnerWorkings that by 2006 was listed on Nasdaq. Mr. Lefkofsky has taught at DePaul University Kellstadt Graduate School of Business, North Western University Kellogg School of Management and currently is an adjunct professor at University of Chicago Booth School of Business. He serves on the board of directors at Children’s Memorial Hospital, the Art Institute of Chicago and is Chairman of the Board of Trustees of Chicago Steppenwolf Theater Company.
To know more visit @: www.tempus.com/about-us/